Global Cancer Biological Therapy Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • ID:PD036910
  • August 2019
  • GIR (Global Info Research)
                          

The Global Cancer Biological Therapy Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies.

Scope of the Report:
North America dominates a major share of the global Cancer Biological Therapy market.

On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc. 

The worldwide market for Cancer Biological Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Cancer Biological Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  •  ELI Lilly
  •  Sanofi
  •  Merck
  •  Bayer
  •  Roche
  •  Novartis International
  •  Pfizer
  •  Bristol-Myers Squibb
  •  Seattle Genetics
  •  Amgen
  •  Takeda Pharmaceuticals
  •  GlaxoSmithKline
  •  Spectrum Pharmaceuticals
  •  Celgene Corporation
  •  AstraZeneca, Plc.
  •  Otsuka
  •  Eisai
  •  Abbvie
  •  Incyte

Market Segment by Regions, regional analysis covers
  •  North America (United States, Canada and Mexico)
  •  Europe (Germany, France, UK, Russia and Italy)
  •  Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  •  South America (Brazil, Argentina, Colombia etc.)
  •  Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •  Monoclonal Antibodies
  •  Vaccines
  •  Cancer Growth Blockers
  •  Blood Cell Growth Factors

Market Segment by Applications, can be divided into
  •  Hospitals
  •  Diagnostic Laboratories
  •  Research & Academic Laboratories
  •  Pharmaceutical & Biotechnology Companies

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Biological Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Biological Therapy, with price, sales, revenue and global market share of Cancer Biological Therapy in 2017 and 2018.
Chapter 3, the Cancer Biological Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Biological Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Cancer Biological Therapy market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Cancer Biological Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Cancer Biological Therapy Introduction
    1.2 Market Analysis by Type
        1.2.1 Monoclonal Antibodies
        1.2.2 Vaccines
        1.2.3 Cancer Growth Blockers
        1.2.4 Blood Cell Growth Factors
    1.3 Market Analysis by Applications
        1.3.1 Hospitals
        1.3.2 Diagnostic Laboratories
        1.3.3 Research & Academic Laboratories
        1.3.4 Pharmaceutical & Biotechnology Companies
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2014-2024)
            1.4.1.2 Canada Market States and Outlook (2014-2024)
            1.4.1.3 Mexico Market States and Outlook (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2014-2024)
            1.4.2.2 France Market States and Outlook (2014-2024)
            1.4.2.3 UK Market States and Outlook (2014-2024)
            1.4.2.4 Russia Market States and Outlook (2014-2024)
            1.4.2.5 Italy Market States and Outlook (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2014-2024)
            1.4.3.2 Japan Market States and Outlook (2014-2024)
            1.4.3.3 Korea Market States and Outlook (2014-2024)
            1.4.3.4 India Market States and Outlook (2014-2024)
            1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2014-2024)
            1.4.4.2 Egypt Market States and Outlook (2014-2024)
            1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
            1.4.4.4 South Africa Market States and Outlook (2014-2024)
            1.4.4.5 Turkey Market States and Outlook (2014-2024)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 ELI Lilly
        2.1.1 Business Overview
        2.1.2 Cancer Biological Therapy Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 ELI Lilly Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Sanofi
        2.2.1 Business Overview
        2.2.2 Cancer Biological Therapy Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Sanofi Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Merck
        2.3.1 Business Overview
        2.3.2 Cancer Biological Therapy Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Merck Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Bayer
        2.4.1 Business Overview
        2.4.2 Cancer Biological Therapy Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Bayer Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Roche
        2.5.1 Business Overview
        2.5.2 Cancer Biological Therapy Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Roche Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.6 Novartis International
        2.6.1 Business Overview
        2.6.2 Cancer Biological Therapy Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Novartis International Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Pfizer
        2.7.1 Business Overview
        2.7.2 Cancer Biological Therapy Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Pfizer Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.8 Bristol-Myers Squibb
        2.8.1 Business Overview
        2.8.2 Cancer Biological Therapy Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Bristol-Myers Squibb Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Seattle Genetics
        2.9.1 Business Overview
        2.9.2 Cancer Biological Therapy Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Seattle Genetics Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.10 Amgen
        2.10.1 Business Overview
        2.10.2 Cancer Biological Therapy Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Amgen Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.11 Takeda Pharmaceuticals
        2.11.1 Business Overview
        2.11.2 Cancer Biological Therapy Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 Takeda Pharmaceuticals Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.12 GlaxoSmithKline
        2.12.1 Business Overview
        2.12.2 Cancer Biological Therapy Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 GlaxoSmithKline Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.13 Spectrum Pharmaceuticals
        2.13.1 Business Overview
        2.13.2 Cancer Biological Therapy Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 Spectrum Pharmaceuticals Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.14 Celgene Corporation
        2.14.1 Business Overview
        2.14.2 Cancer Biological Therapy Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 Celgene Corporation Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.15 AstraZeneca, Plc.
        2.15.1 Business Overview
        2.15.2 Cancer Biological Therapy Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 AstraZeneca, Plc. Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.16 Otsuka
        2.16.1 Business Overview
        2.16.2 Cancer Biological Therapy Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Otsuka Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.17 Eisai
        2.17.1 Business Overview
        2.17.2 Cancer Biological Therapy Type and Applications
            2.17.2.1 Product A
            2.17.2.2 Product B
        2.17.3 Eisai Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.18 Abbvie
        2.18.1 Business Overview
        2.18.2 Cancer Biological Therapy Type and Applications
            2.18.2.1 Product A
            2.18.2.2 Product B
        2.18.3 Abbvie Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    2.19 Incyte
        2.19.1 Business Overview
        2.19.2 Cancer Biological Therapy Type and Applications
            2.19.2.1 Product A
            2.19.2.2 Product B
        2.19.3 Incyte Cancer Biological Therapy Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Biological Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
    3.1 Global Cancer Biological Therapy Sales and Market Share by Manufacturer (2017-2018)
    3.2 Global Cancer Biological Therapy Revenue and Market Share by Manufacturer (2017-2018)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Cancer Biological Therapy Manufacturer Market Share in 2018
        3.3.2 Top 6 Cancer Biological Therapy Manufacturer Market Share in 2018
    3.4 Market Competition Trend
4 Global Cancer Biological Therapy Market Analysis by Regions
    4.1 Global Cancer Biological Therapy Sales, Revenue and Market Share by Regions
        4.1.1 Global Cancer Biological Therapy Sales and Market Share by Regions (2014-2019)
        4.1.2 Global Cancer Biological Therapy Revenue and Market Share by Regions (2014-2019)
    4.2 North America Cancer Biological Therapy  Sales and Growth Rate (2014-2019)
    4.3 Europe Cancer Biological Therapy  Sales and Growth Rate (2014-2019)
    4.4 Asia-Pacific Cancer Biological Therapy  Sales and Growth Rate (2014-2019)
    4.5 South America Cancer Biological Therapy  Sales and Growth Rate (2014-2019)
    4.6 Middle East and Africa Cancer Biological Therapy  Sales and Growth Rate (2014-2019)
5 North America Cancer Biological Therapy by Country
    5.1 North America Cancer Biological Therapy Sales, Revenue and Market Share by Country
        5.1.1 North America Cancer Biological Therapy Sales and Market Share by Country (2014-2019)
        5.1.2 North America Cancer Biological Therapy Revenue and Market Share by Country (2014-2019)
    5.2 United States Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    5.3 Canada Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    5.4 Mexico Cancer Biological Therapy Sales and Growth Rate (2014-2019)
6 Europe Cancer Biological Therapy by Country
    6.1 Europe Cancer Biological Therapy Sales, Revenue and Market Share by Country
        6.1.1 Europe Cancer Biological Therapy Sales and Market Share by Country (2014-2019)
        6.1.2 Europe Cancer Biological Therapy Revenue and Market Share by Country (2014-2019)
    6.2 Germany Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    6.3 UK Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    6.4 France Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    6.5 Russia Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    6.6 Italy Cancer Biological Therapy Sales and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Biological Therapy by Country
    7.1 Asia-Pacific Cancer Biological Therapy Sales, Revenue and Market Share by Country
        7.1.1 Asia-Pacific Cancer Biological Therapy Sales and Market Share by Country (2014-2019)
        7.1.2 Asia-Pacific Cancer Biological Therapy Revenue and Market Share by Country (2014-2019)
    7.2 China Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    7.3 Japan Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    7.4 Korea Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    7.5 India Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    7.6 Southeast Asia Cancer Biological Therapy Sales and Growth Rate (2014-2019)
8 South America Cancer Biological Therapy by Country
    8.1 South America Cancer Biological Therapy Sales, Revenue and Market Share by Country
        8.1.1 South America Cancer Biological Therapy Sales and Market Share by Country (2014-2019)
        8.1.2 South America Cancer Biological Therapy Revenue and Market Share by Country (2014-2019)
    8.2 Brazil Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    8.3 Argentina Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    8.4 Colombia Cancer Biological Therapy Sales and Growth Rate (2014-2019)
9 Middle East and Africa Cancer Biological Therapy by Countries
    9.1 Middle East and Africa Cancer Biological Therapy Sales, Revenue and Market Share by Country
        9.1.1 Middle East and Africa Cancer Biological Therapy Sales and Market Share by Country (2014-2019)
        9.1.2 Middle East and Africa Cancer Biological Therapy Revenue and Market Share by Country (2014-2019)
    9.2 Saudi Arabia Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    9.3 Turkey Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    9.4 Egypt Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    9.5 Nigeria Cancer Biological Therapy Sales and Growth Rate (2014-2019)
    9.6 South Africa Cancer Biological Therapy Sales and Growth Rate (2014-2019)
10 Global Cancer Biological Therapy Market Segment by Type
    10.1 Global Cancer Biological Therapy Sales, Revenue and Market Share by Type (2014-2019)
        10.1.1 Global Cancer Biological Therapy Sales and Market Share by Type (2014-2019)
        10.1.2 Global Cancer Biological Therapy Revenue and Market Share by Type (2014-2019)
    10.2 Monoclonal Antibodies Sales Growth and Price
        10.2.1 Global Monoclonal Antibodies Sales Growth (2014-2019)
        10.2.2 Global Monoclonal Antibodies Price (2014-2019)
    10.3 Vaccines Sales Growth and Price
        10.3.1 Global Vaccines Sales Growth (2014-2019)
        10.3.2 Global Vaccines Price (2014-2019)
    10.4 Cancer Growth Blockers Sales Growth and Price
        10.4.1 Global Cancer Growth Blockers Sales Growth (2014-2019)
        10.4.2 Global Cancer Growth Blockers Price (2014-2019)
    10.5 Blood Cell Growth Factors Sales Growth and Price
        10.5.1 Global Blood Cell Growth Factors Sales Growth (2014-2019)
        10.5.2 Global Blood Cell Growth Factors Price (2014-2019)
11 Global Cancer Biological Therapy Market Segment by Application
    11.1 Global Cancer Biological Therapy Sales Market Share by Application (2014-2019)
    11.2 Hospitals Sales Growth (2014-2019)
    11.3 Diagnostic Laboratories Sales Growth (2014-2019)
    11.4 Research & Academic Laboratories Sales Growth (2014-2019)
    11.5 Pharmaceutical & Biotechnology Companies Sales Growth (2014-2019)
12 Cancer Biological Therapy Market Forecast (2019-2024)
    12.1 Global Cancer Biological Therapy Sales, Revenue and Growth Rate (2019-2024)
    12.2 Cancer Biological Therapy Market Forecast by Regions (2019-2024)
        12.2.1 North America Cancer Biological Therapy Market Forecast (2019-2024)
        12.2.2 Europe Cancer Biological Therapy Market Forecast (2019-2024)
        12.2.3 Asia-Pacific Cancer Biological Therapy Market Forecast (2019-2024)
        12.2.4 South America Cancer Biological Therapy Market Forecast (2019-2024)
        12.2.5 Middle East and Africa Cancer Biological Therapy Market Forecast (2019-2024)
    12.3 Cancer Biological Therapy Market Forecast by Type (2019-2024)
        12.3.1 Global Cancer Biological Therapy Sales Forecast by Type (2019-2024)
        12.3.2 Global Cancer Biological Therapy Market Share Forecast by Type (2019-2024)
    12.4 Cancer Biological Therapy Market Forecast by Application (2019-2024)
        12.4.1 Global Cancer Biological Therapy Sales Forecast by Application (2019-2024)
        12.4.2 Global Cancer Biological Therapy Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Related Reports
Global Population Health Management Market Research Report 2017

The Global Population Health Management Market Research Report provides a detailed market overview along with the analysis of industry’s gross  read more..


Global Water Distiller Market Insights, Forecast to 2025

Water Distiller Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Report 2017

The EMEA (Europe, Middle East and Africa) Hepatitis A Vaccine Market Research Report provides a detailed market overview along with the analysis of  read more..


Global Health Insurance Market Report 2019-2025

The Health Insurance market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report also  read more..


Global Boat First Aid Kits Industry 2016 Market Research Report

The Global Boat First Aid Kits Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Boat First Aid Kits  read more..


Global Facial Aesthetics Market Report 2018-2025

The Global Facial Aesthetics Market report is a recent research added by DecisionDatabases.com, offers critical insight into the market dynamic. This  read more..


Global Spinal Fixation Systems Market Research Report 2017

The Global Spinal Fixation Systems Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin,  read more..


Global Vascular Graft Market Insights, Forecast to 2025

Vascular Graft Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Blood Products Market Insights, Forecast to 2025

Blood Products Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Nateglinide Market Research Report 2021

The Global Nateglinide Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..